1. |
[1]Zheng QS, Sun RY, Chen ZY. Sample size estimation and equivalence margin in noninferiority and equivalence trials [ J ].Chinese Journal New Drugs, 2003; 12 ( 5 ): 368-371.
|
2. |
鄭青山,孫瑞元,陳志揚.新藥臨床試驗樣本估計的簡捷算法和等效標準探討[J].中國新藥雜志,2003;12(5):368~371.
|
3. |
[2]Zheng QS, Sun RY, Chen ZY. Lowest sample size and its safety in clinical trials in China [ J ]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2003; 8 ( 3 ): 354-355.
|
4. |
鄭青山,孫瑞元,陳志揚新藥臨床試驗最低例數規定的安全性分析[J]中國臨床藥理學與治療學,2003;8(3):354~355.
|
5. |
[3]Zheng XY. The guide for clinical trials of new drugs [ M ]. 1 st Edition. Beijing: Medical Press Science of Technology of Chiha, 2002:68-73.
|
6. |
鄭筱萸.中藥新藥臨床研究指導原則[M].第1版.北京:中國醫藥科技出版社,2002:68~73.
|
7. |
[4]Zheng QS, Sun RY, Chen ZY. Determination of equivalence of two drugs in clinical trial [ J ]. Chinese Journal of Clinical Pharmacology and Therapeutics ,2002; 7 ( 6 ): 559-561.
|
8. |
鄭青山,孫瑞元,陳志揚.臨床兩組藥物等效的判別方法及其辨析[J].中國臨床藥理學與治療學,2002;7(6):559~561.
|
9. |
[5]Chen ZY, Zheng QS , Sun RY. Function of the DAS Software for pharmacological calculation[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2002; 7 ( 6 ): 562-564.
|
10. |
陳志揚,鄭青山,孫瑞元大型藥理學計算軟件DAS的功能介紹[J].中國臨床藥理學與治療學,2002;7(6):562~564.
|
11. |
[6]Zheng QS, Sun RY. Common questions of rank data and the statistical treatments in pharmacodynamical statistics[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2002; 7 (5): 469-472.
|
12. |
鄭青山,孫瑞元藥效指標等級劃分的常見問題及其數據處理[J].中國臨床藥理學與治療學,2002;7(5):469~472.
|